spacer
home > > spring 2002 > convergent technologies - opportunities in clinical trials
PUBLICATIONS


Convergent Technologies - Opportunities in Clinical Trials

In the Beginning...

It can be argued that the first true remote data entry tool was an interactive voice response (IVR) system. An IVR will allow you to collect data for a clinical trial from anywhere in the world, at any time of the day or night. All IVR systems use the same interface - a telephone handset with 12 possible responses. What could be better? Worldwide access and a standard user interface that is very simple to use.

Then came the Internet. Now all we hear about is the World Wide Web, the Internet and how IVR is a dying technology. Every clinical trial manager with more than two weeks' experience has heard the electronic data capture (EDC) sales pitch. For the last five years EDC vendors have been saying: "In the next five years, all clinical trials will be paperless". Of course, no-one wants to talk about the costs of outfitting 250 sites around the world with computers, Internet connectivity and end user training. Secondly, what happens in those countries where less than five per cent of the population have access to a computer?

Naturally, both technologies have benefits and limitations. Whilst IVR has a simple interface, it is very cumbersome on complex systems. The web interface can handle a complex system, but at what cost? What if we were able to converge both technologies and create a combination that is better than one on its own? A technology alloy!


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Kris Gustafson, Director of Interactive Technologies, and Joanna Williams, IVRS Project Director for ICON Clinical Research

Kris Gustafson, BS, MCSE, CNE is Director of Interactive Technologies for ICON Clinical Research. Over the past eight years he has developed hundreds of interactive voice response systems for clinical trials. Kris continues to improve current processes while adapting the current technology to provide trial management solutions.

Joanna Williams is the IVRS Project Director for ICON Clinical Research. She has been involved in pharmaceutical clinical research for over seven years and has extensive experience of designing and managing interactive voice response and web-based systems for clinical trials. Joanna is currently responsible for all aspects of IVRS project management activities at ICON.

spacer
Kris Gustafson
spacer
spacer
spacer
Joanna Williams
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

IMFINZITM (durvalumab) WITH CHEMOTHERAPY DEMONSTRATED A SUSTAINED OVERALL SURVIVAL BENEFIT IN 1ST-LINE EXTENSIVE-STAGE SMALL CELL LUNG CANCER IN THE PHASE III CASPIAN TRIAL

Detailed results from an updated analysis of the Phase III CASPIAN trial showed AstraZeneca’s Imfinzi (durvalumab) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained, clinically meaningful overall survival (OS) benefit for adults with extensive-stage small cell lung cancer (ES-SCLC) treated in the 1st-line setting.
More info >>

White Papers
 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement